インディアナ州における潰瘍性大腸炎の臨床試験
インディアナ州内の拠点で、潰瘍性大腸炎に関する9件の研究が参加者を募集しています。
インディアナ州内の都市
公式研究テキスト（英語）
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
- IU Health University Hospital, Indianapolis
被験者募集中第3相
12歳以上 · 全性別 · 2026/09/25更新 · NCT07196748A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Riley Hospital for Children, Indianapolis
被験者募集中第3相
3歳以上 · 全性別 · 2026/09/25更新 · NCT06663332A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
- Local Institution - 0100, Indianapolis
被験者募集中第2/3相
2歳〜17歳 · 全性別 · 2026/09/24更新 · NCT05076175Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Indiana University Health University Hospital, Indianapolis
- Gastroenterology Health Partners, New Albany
被験者募集中第3相
18歳〜70歳 · 全性別 · 2026/09/24更新 · NCT06937086LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Gastroenterology Health Partners, New Albany
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/22更新 · NCT07186101LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- Gastroenterology Health Partners, New Albany
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/22更新 · NCT07415044A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Gastroenterology Health Partners, PLLC - New Albany - Site Number: 8400100, New Albany
被験者募集中第3相
16歳〜80歳 · 全性別 · 2026/09/15更新 · NCT07185009An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Gastroenterology Health Partners, PLLC - Site Number: 8400100, New Albany
被験者募集中第3相
16歳〜80歳 · 全性別 · 2026/08/20更新 · NCT07184996Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis
- Bausch Health Site 003, Indianapolis
被験者募集中第4相
5歳〜17歳 · 全性別 · 2025/09/16更新 · NCT04314375ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。